Wespac Advisors So Cal, LLC Vertex Pharmaceuticals Inc Transaction History

Wespac Advisors So Cal, LLC

  • $426 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 14, 2021
SELL
$181.39 - $202.99 $1.45 Million - $1.62 Million
-7,975 Closed
0 $0
Q2 2021

Jul 29, 2021
BUY
$187.49 - $221.1 $878,390 - $1.04 Million
4,685 Added 142.4%
7,975 $1.61 Million
Q1 2021

Apr 30, 2021
BUY
$207.02 - $241.31 $62,106 - $72,393
300 Added 10.03%
3,290 $707,000
Q4 2020

Feb 02, 2021
BUY
$207.01 - $276.09 $618,959 - $825,509
2,990 New
2,990 $707,000

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Wespac Advisors So Cal, LLC Portfolio

Follow Wespac Advisors So Cal, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email